Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
98 | 3 | STATINS//JOURNAL OF LIPID RESEARCH//LIPOPROTEINS | 77402 |
373 | 2 | STATINS//EZETIMIBE//SIMVASTATIN | 17683 |
406 | 1 | STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN | 3532 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | STATINS | authKW | 313875 | 15% | 7% | 520 |
2 | LOW DENSITY LIPOPROTEIN CHOLESTEROL | authKW | 128758 | 3% | 13% | 109 |
3 | ATORVASTATIN | authKW | 117423 | 4% | 8% | 158 |
4 | LIPID LOWERING | authKW | 104266 | 1% | 24% | 48 |
5 | ROSUVASTATIN | authKW | 103167 | 3% | 13% | 91 |
6 | LIPID LOWERING DRUGS | authKW | 90836 | 1% | 23% | 44 |
7 | HYPERCHOLESTEROLEMIA | authKW | 85784 | 5% | 5% | 191 |
8 | LIPID LOWERING THERAPY | authKW | 67741 | 1% | 20% | 38 |
9 | CORONARY HEART DISEASE | authKW | 65812 | 6% | 3% | 227 |
10 | HMG COA REDUCTASE INHIBITORS | authKW | 58604 | 2% | 8% | 83 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 31821 | 37% | 0% | 1323 |
2 | Medicine, General & Internal | 15976 | 31% | 0% | 1110 |
3 | Peripheral Vascular Diseases | 3304 | 10% | 0% | 338 |
4 | Health Care Sciences & Services | 2145 | 6% | 0% | 202 |
5 | Pharmacology & Pharmacy | 1798 | 15% | 0% | 541 |
6 | Health Policy & Services | 1387 | 4% | 0% | 125 |
7 | Primary Health Care | 1351 | 2% | 0% | 72 |
8 | Geriatrics & Gerontology | 405 | 2% | 0% | 75 |
9 | Endocrinology & Metabolism | 291 | 5% | 0% | 168 |
10 | Medicine, Research & Experimental | 135 | 4% | 0% | 126 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANAL COST EFFECT CARE | 58542 | 0% | 41% | 16 |
2 | SECT ATHEROSCLEROSIS LIPID | 37171 | 0% | 83% | 5 |
3 | US MED SCI AFFAIRS | 29136 | 0% | 47% | 7 |
4 | CHOLESTEROL EDUC PROGRAM | 28547 | 0% | 80% | 4 |
5 | CARDIAC REHABIL CHOLESTEROL CLIN | 20072 | 0% | 75% | 3 |
6 | HEART DIS PREVENT CLIN | 19861 | 0% | 32% | 7 |
7 | DIENST ENDOCRINOL METAB VOEDING | 17843 | 0% | 100% | 2 |
8 | GHEHCLUMR 1060CARMEN | 17843 | 0% | 100% | 2 |
9 | HLTH AGINGCSS | 17843 | 0% | 100% | 2 |
10 | INSERMLNCUMR 866 | 17843 | 0% | 100% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | AMERICAN JOURNAL OF CARDIOLOGY | 33479 | 9% | 1% | 319 |
2 | ATHEROSCLEROSIS SUPPLEMENTS | 18114 | 1% | 8% | 24 |
3 | AMERICAN JOURNAL OF MANAGED CARE | 14203 | 2% | 2% | 67 |
4 | CARDIOVASCULAR THERAPY AND PREVENTION | 12978 | 1% | 4% | 33 |
5 | EUROPEAN HEART JOURNAL SUPPLEMENTS | 12595 | 1% | 4% | 39 |
6 | CURRENT MEDICAL RESEARCH AND OPINION | 9671 | 2% | 2% | 71 |
7 | JOURNAL OF CARDIOVASCULAR RISK | 9486 | 0% | 7% | 16 |
8 | CURRENT OPINION IN LIPIDOLOGY | 8382 | 1% | 3% | 36 |
9 | CLINICAL THERAPEUTICS | 7803 | 2% | 1% | 67 |
10 | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 7061 | 2% | 1% | 58 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |